Macrothrombocytopenia of Takenouchi-Kosaki syndrome is ameliorated by CDC42 specific- and lipidation inhibitors in MEG-01 cells
Abstract Macrothrombocytopenia is a common pathology of missense mutations in genes regulating actin dynamics. Takenouchi-Kosaki syndrome (TKS) harboring the c.191A > G, Tyr64Cys (Y64C) variant in Cdc42 exhibits a variety of clinical manifestations, including immunological and hematological anoma...
Guardado en:
Autores principales: | Etsuko Daimon, Yukinao Shibukawa, Suganya Thanasegaran, Natsuko Yamazaki, Nobuhiko Okamoto |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/421a4557f37544e488a883474ac7b586 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis
por: Xin Duan, et al.
Publicado: (2021) -
Remediation of ABCG5-Linked Macrothrombocytopenia With Ezetimibe Therapy
por: Libin Deng, et al.
Publicado: (2021) -
Optogenetic dissection of Rac1 and Cdc42 gradient shaping
por: S. de Beco, et al.
Publicado: (2018) -
MicroRNA-29a suppresses the growth of human cervical cancer cells by targeting cell division cycle 42 (CDC42)
por: Fang Song, et al.
Publicado: (2021) -
The Shp2-induced epithelial disorganization defect is reversed by HDAC6 inhibition independent of Cdc42
por: Sui-Chih Tien, et al.
Publicado: (2016)